N/A N=71 Randomized Single-blind Treatment

Pilot Study of Motivational Interviewing for Loved Ones

Psychotic Disorders · Psychosis · Psychotic Episode

Bottom Line

View on ClinicalTrials.gov: NCT04010747 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2023

Primary outcome: Primary: Change in the Number of Mental Health Related Appointments Attended by the Individual With Psychosis (IP) in the Past 30 Days — 0.29; -1.06 number of appointments

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Motivational Interviewing for Loved Ones (MILO) (Behavioral); Mental Health Services Consultation and Waitlist (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Boston Medical Center
Primary completion: Apr 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in the Number of Mental Health Related Appointments Attended by the Individual With Psychosis (IP) in the Past 30 Days	0.29; -1.06	—
SECONDARY Change in Parents and Concerned Significant Others (PCSO) Expressed Emotion	-7.82; -7.0	—
SECONDARY Change in Parents and Concerned Significant Others (PCSO) Distress	-3.91; -4.47	—

Summary

The study population for this research will include parents and concerned significant others (PCSO) of individuals experiencing recent (past five years) onset of a psychotic disorder (hereafter referred to as individuals with psychosis, "IP") who are not currently engaged with, or at risk for disengagement from, treatment. MILO is a brief and structured intervention that teaches motivational interviewing communication strategies. The initial aim (phase 1) of this pilot study is to evaluate feasibility of the intervention. The secondary aims are to evaluate the effectiveness of MILO for (1) enhancing the engagement of IP with evidence-based treatments and (2) reducing distress among PCSO. The investigators hypothesize that the intervention will be superior to control condition for both enhancing IP engagement with mental health services and reducing PCSO distress.

Eligibility Criteria

Inclusion Criteria

Age 18 or older
Primary caregiver or other close contact of an individual within first 5 years of onset of a psychotic disorder who is poorly engaged or unengaged in psychiatric treatment

Exclusion Criteria

Not able to provide informed consent
Not proficient in English
History of developmental delay
Current acute mental health problem or distress

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04010747). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.